Dale L Phelps1, Robert M Ward2, Rick L Williams3, Tracy L Nolen3, Kristi L Watterberg4, William Oh5, Michael Goedecke3, Richard A Ehrenkranz6, Timothy Fennell7, Brenda B Poindexter8, C Michael Cotten9, Mikko Hallman10, Ivan D Frantz11, Roger G Faix2, Kristin M Zaterka-Baxter3, Abhik Das12, M Bethany Ball13, Conra Backstrom Lacy4, Michele C Walsh14, Waldemar A Carlo15, Pablo J Sánchez16, Edward F Bell17, Seetha Shankaran18, David P Carlton19, Patricia R Chess1, Rosemary D Higgins20. 1. Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York. 2. Department of Pediatrics, and Pediatric Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah. 3. Social, Statistical and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina. 4. Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico. 5. Department of Pediatrics, Women & Infants' Hospital Brown University, Providence, Rhode Island. 6. Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut. 7. Pharmacology and Toxicology Division, RTI International, Research Triangle Park, North Carolina. 8. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana. 9. Department of Pediatrics, Duke University, Durham, North Carolina. 10. PEDEGO Research Center, and MRC Oulu, and Oulu University Hospital, Oulu, Finland. 11. Department of Pediatrics, Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts. 12. Social, Statistical and Environmental Sciences Unit, RTI International, Rockville, Maryland. 13. Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto, California. 14. Department of Pediatrics, Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, Ohio. 15. Department of Pediatrics, Division of Neonatology, University of Alabama at Birmingham, Birmingham, Alabama. 16. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. 17. Department of Pediatrics, University of Iowa, Iowa City, Iowa. 18. Department of Pediatrics, Wayne State University, Detroit, Michigan. 19. Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia. 20. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Abstract
BACKGROUND:Preterm infants with respiratory distress syndrome (RDS) given inositol had reduced bronchopulmonary dysplasia (BPD), death and severe retinopathy of prematurity (ROP). We assessed the safety and pharmacokinetics of daily inositol to select a dose providing serum levels previously associated with benefit, and to learn if accumulation occurred when administered throughout the normal period of retinal vascularization. METHODS:Infants ≤ 29 wk GA (n = 122, 14 centers) were randomized and treated with placebo or inositol at 10, 40, or 80 mg/kg/d. Intravenous administration converted to enteral when feedings were established, and continued to the first of 10 wk, 34 wk postmenstrual age (PMA) or discharge. Serum collection employed a sparse sampling population pharmacokinetics design. Inositol urine losses and feeding intakes were measured. Safety was prospectively monitored. RESULTS: At 80 mg/kg/d mean serum levels reached 140 mg/l, similar to Hallman's findings. Levels declined after 2 wk, converging in all groups by 6 wk. Analyses showed a mean volume of distribution 0.657 l/kg, clearance 0.058 l/kg/h, and half-life 7.90 h. Adverse events and comorbidities were fewer in the inositol groups, but not significantly so. CONCLUSION: Multiple dose inositol at 80 mg/kg/d was not associated with increased adverse events, achieves previously effective serum levels, and is appropriate for investigation in a phase III trial.
RCT Entities:
BACKGROUND: Preterm infants with respiratory distress syndrome (RDS) given inositol had reduced bronchopulmonary dysplasia (BPD), death and severe retinopathy of prematurity (ROP). We assessed the safety and pharmacokinetics of daily inositol to select a dose providing serum levels previously associated with benefit, and to learn if accumulation occurred when administered throughout the normal period of retinal vascularization. METHODS:Infants ≤ 29 wk GA (n = 122, 14 centers) were randomized and treated with placebo or inositol at 10, 40, or 80 mg/kg/d. Intravenous administration converted to enteral when feedings were established, and continued to the first of 10 wk, 34 wk postmenstrual age (PMA) or discharge. Serum collection employed a sparse sampling population pharmacokinetics design. Inositol urine losses and feeding intakes were measured. Safety was prospectively monitored. RESULTS: At 80 mg/kg/d mean serum levels reached 140 mg/l, similar to Hallman's findings. Levels declined after 2 wk, converging in all groups by 6 wk. Analyses showed a mean volume of distribution 0.657 l/kg, clearance 0.058 l/kg/h, and half-life 7.90 h. Adverse events and comorbidities were fewer in the inositol groups, but not significantly so. CONCLUSION: Multiple dose inositol at 80 mg/kg/d was not associated with increased adverse events, achieves previously effective serum levels, and is appropriate for investigation in a phase III trial.
Authors: Barbara J Stoll; Nellie I Hansen; Edward F Bell; Seetha Shankaran; Abbot R Laptook; Michele C Walsh; Ellen C Hale; Nancy S Newman; Kurt Schibler; Waldemar A Carlo; Kathleen A Kennedy; Brenda B Poindexter; Neil N Finer; Richard A Ehrenkranz; Shahnaz Duara; Pablo J Sánchez; T Michael O'Shea; Ronald N Goldberg; Krisa P Van Meurs; Roger G Faix; Dale L Phelps; Ivan D Frantz; Kristi L Watterberg; Shampa Saha; Abhik Das; Rosemary D Higgins Journal: Pediatrics Date: 2010-08-23 Impact factor: 7.124
Authors: James D Reynolds; Velma Dobson; Graham E Quinn; Alistair R Fielder; Earl A Palmer; Richard A Saunders; Robert J Hardy; Dale L Phelps; John D Baker; Michael T Trese; David Schaffer; Betty Tung Journal: Arch Ophthalmol Date: 2002-11
Authors: Ira Adams-Chapman; Carla M Bann; Abhik Das; Ronald N Goldberg; Barbara J Stoll; Michele C Walsh; Pablo J Sánchez; Rosemary D Higgins; Seetha Shankaran; Kristi L Watterberg; Shahnaz Duara; Nancy A Miller; Roy J Heyne; Myriam Peralta-Carcelen; Ricki F Goldstein; Jean J Steichen; Charles R Bauer; Susan R Hintz; Patricia W Evans; Michael J Acarregui; Gary J Myers; Betty R Vohr; Deanne E Wilson-Costello; Athina Pappas; Yvonne E Vaucher; Richard A Ehrenkranz; Elisabeth C McGowan; Robert G Dillard; Janell Fuller; Daniel K Benjamin Journal: J Pediatr Date: 2013-05-30 Impact factor: 4.406
Authors: Clément Larrue; Nastassja K Scheidegger; Shan Lin; Bo Kyung A Seong; Neekesh V Dharia; Miljan Kuljanin; Caroline S Wechsler; Guillaume Kugener; Amanda L Robichaud; Amy Saur Conway; Thelma Mashaka; Sarah Mouche; Biniam Adane; Jeremy A Ryan; Joseph D Mancias; Scott T Younger; Federica Piccioni; Lynn H Lee; Mark Wunderlich; Anthony Letai; Jérôme Tamburini; Kimberly Stegmaier Journal: Cancer Discov Date: 2021-09-16 Impact factor: 38.272
Authors: Dale L Phelps; Kristi L Watterberg; Tracy L Nolen; Carol A Cole; C Michael Cotten; William Oh; Brenda B Poindexter; Kristin M Zaterka-Baxter; Abhik Das; Conra Backstrom Lacy; Ann Marie Scorsone; Michele C Walsh; Edward F Bell; Kathleen A Kennedy; Kurt Schibler; Gregory M Sokol; Matthew M Laughon; Satyanarayana Lakshminrusimha; William E Truog; Meena Garg; Waldemar A Carlo; Abbot R Laptook; Krisa P Van Meurs; David P Carlton; Amanda Graf; Sara B DeMauro; Luc P Brion; Seetha Shankaran; Faruk H Orge; Richard J Olson; Helen Mintz-Hittner; Michael B Yang; Kathryn M Haider; David K Wallace; Mina Chung; Denise Hug; Irena Tsui; Martin S Cogen; John P Donahue; Michael Gaynon; Amy K Hutchinson; Don L Bremer; Graham Quinn; Yu-Guang He; William R Lucas; Timothy W Winter; Stephen D Kicklighter; Kartik Kumar; Patricia R Chess; Tarah T Colaizy; Anna Marie Hibbs; Namasivayam Ambalavanan; Heidi M Harmon; Elisabeth C McGowan; Rosemary D Higgins Journal: JAMA Date: 2018-10-23 Impact factor: 56.272
Authors: Leeann R Pavlek; Brian K Rivera; Charles V Smith; Joanie Randle; Cory Hanlon; Kristi Small; Edward F Bell; Matthew A Rysavy; Sara Conroy; Carl H Backes Journal: J Pediatr Date: 2021-04-21 Impact factor: 6.314
Authors: Luc P Brion; Dale L Phelps; Robert M Ward; Tracy L Nolen; N Mikko K Hallman; Abhik Das; Daniel J Zaccaro; M Bethany Ball; Kristi L Watterberg; Ivan D Frantz; C Michael Cotten; Brenda B Poindexter; William Oh; Ralph A Lugo; Krisa P Van Meurs; T Michael O'Shea; Kristin M Zaterka-Baxter; Rosemary D Higgins Journal: J Perinatol Date: 2020-09-15 Impact factor: 2.521
Authors: Jenna E Koschnitzky; Richard F Keep; David D Limbrick; James P McAllister; Jill A Morris; Jennifer Strahle; Yun C Yung Journal: Fluids Barriers CNS Date: 2018-03-27